Management of Hypertension

The management of hypertension in kidney diseases is for the most part in view of the administration of medications which can reduce proteinuria and to slowdowns the dynamic functional deterioration. Angiotensin-changing over chemical inhibitors (ACEI), which bring down both proteinuria and blood pressure, have developed as medications of choice in proteinuric patients with either typical renal function or mild to moderate  kidney failure. In non proteinuric nephropathies no controlled examinations exist showing the prevalence of ACEI over different medications. In these conditions calcium antagonists may likewise be utilized. The way to deal with patients with hypertension and renal illness ought to dependably take into consideration over the nature of the outcomes that are to be accomplished. If the aim is to lower proteinuria and slow down progression, at that point ACEI, conceivably connected with calcium adversaries, are the medications of choice.

  • Diabetes Management
  • Urogynecology
  • Glomerulonephritis
  • Lowering blood pressure
  • Maintenance therapy and reassessment

Related Conference of Management of Hypertension

May 14-15, 2018

19th Global Nephrologists Annual Meeting

Rome, Italy
July 23-24, 2018

15th International Conference on Nephrology and Hypertension

Kuala Lumpur, Malaysia
October 08-10, 2018

3rd World Kidney Congress

Dubai, UAE
July 23-24, 2018

14th World Nephrology Conference

Melbourne, Australia
October 15-16, 2018

22nd European Nephrology Conference

Warsaw, Poland
October 19-20, 2018

3rd Annual Kidney Congress

New York City, New York, USA
October 19-20, 2018

16th International Conference on Nephrology & Therapeutics

New York City, New York, USA
November 19-21, 2018

International Conference on Nephrology

Cape Town, South Africa
Nov 27-29, 2018

Annual Congress on Nephrology

Athens, Greece

Management of Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in